Desk› Services› Norris Medicines Ltd
Norris Medicines Ltd
Filing rhythm · 60 trading days
7 filings · 4 material · busiest 2026-08-14
What it files
Filings
7 in the window
-
14 August 2026
Board OutcomeBoard Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026, Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Board Meeting held on August 14, 2026 for the quarter ended June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
14 August 2026
ResultsFinancial Results For The Quarter Ended June 30, 2026
Financial Results for the Quarter ended June 30,2026
Result / Financial Results View filing →
-
14 August 2026
Change in ManagementChange in Management
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September, ....
Company Update / Change in Management View filing →
-
30 July 2026
OutcomeBoard Meeting Outcome for Outcome Of The Board Meeting Dated 30Th July, 2026.
Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Others / Outcome without intimation View filing →
-
30 July 2026
Change in ManagementChange in Management
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July, 2026.
Company Update / Change in Management View filing →
-
3 July 2026
GeneralCertificate Under Reg. 74 (5) Of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June, 2026.
Company Update / General View filing →
-
24 June 2026
Trading WindowClosure of Trading Window
Intimation for Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →